See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626199_2024_Alpine_Immune_Sciences_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001626199, Alpine Immune Sciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 330,034,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,484,000 |
| 3 | remainder_Assets | 48,334,000 |
| 4 | LiabilitiesCurrent | 41,980,000 |
| 5 | LiabilitiesNoncurrent | 9,931,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,329,228 |
| 9 | ResearchAndDevelopmentExpense | 81,281,720 |
| 10 | remainder_Expenses | 2,793,348 |
| 11 | remainder_Revenues | 202,663,612 |
| 12 | remainder_NetIncome | 9,980,605 |
| 13 | remainder_ComprehensiveNetIncome | -843,166 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 379,852,000 |
| 1 | Liabilities | 51,911,000 |
| 2 | Expenses | 109,404,296 |
| 3 | Revenues | 202,663,612 |
| 4 | StockholdersEquity | 327,941,000 |
| 5 | NetIncome | 103,239,921 |
| 6 | ComprehensiveNetIncome | 102,818,338 |
| 7 | BaseVar | 377,327,340 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.79 |
| 9 | EconomicCapitalRatio | 4.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
